Hilary Clinton to Deliver Keynote at BIO International Convention - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Hilary Clinton to Deliver Keynote at BIO International Convention



Former Secretary of State Hillary Rodham Clinton will deliver a keynote address at the 2014 BIO International Convention in San Diego. The keynote luncheon will take place on Wednesday, June 25 from 12:00 to 1:30 pm PDT. The BIO International Convention offers networking and partnering opportunities and provides insights on major trends affecting the industry. Hillary Rodham Clinton served as the 67th Secretary of State from 2009 until 2013, after nearly four decades in public service.

The keynote session is sponsored by Genentech, and is open to Convention registrants with Convention Access and Convention Access & Partnering badges only.

Source: BIO International Convention

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
41%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?

Click here